[New in hysteroscopy: hysteroscopic morcellators].

Area of Science:

• Gynecology
• Minimally Invasive Surgery

Background:

• Hysteroscopic morcellators represent a novel technology for addressing endo-uterine pathologies.
• Existing literature suggests benefits in operative time and fluid usage compared to traditional methods.

Purpose of the Study:

• To review the emerging technology of hysteroscopic morcellators.
• To evaluate the initial clinical experience with the Myosure® hysteroscopic morcellator.

Main Methods:

• A retrospective review of 14 patients undergoing hysteroscopic morcellation using the Myosure® device.
• Data collected included patient demographics, procedure time, fluid deficit, and conversion rates.

Main Results:

• Median procedure time was 26 minutes, with a median fluid deficit of 300 mL.
• Conversion to traditional resectoscopy occurred in 29% of cases.
• High success rates were observed for polyp (100%) and submucous myoma (92%) removal.

Conclusions:

• Hysteroscopic morcellators show promise for treating specific endo-uterine conditions, particularly polyps and Type 0/1 submucous myomas.
• Further experience is needed to overcome the learning curve and optimize outcomes for complex cases.
• While effective, hysteroscopic morcellators currently have limitations in managing large submucous myomas with significant intramyometrial extension.